Launch Of Stelara(R), Offers Psoriasis Patients Significant And Visible Results Maintained With Just Five Doses A Year Janssen-Cilag announced the launch of STELARA (ustekinumab), the first in a new class of biologics, for the treatment of adults with moderate-to-severe plaque psoriasis.
Source: www.medicalnewstoday.comEconomic Downturn Leads U.S. Residents To Skip, Delay Medical Care The AP/Salt Lake Tribune on Wednesday examined how the "ailing economy is leading many Americans to skip doctor visits, skimp on their medicine, and put off mammograms, Pap smears and other tests," a trend that physicians worry will result in "sicker patients who need more expensive treatment later." A
Source: www.medicalnewstoday.comDry Beans Inhibit Development Of Mammary Cancer As the world seeks new ways to prevent and treat chronic diseases such as diabetes, heart disease and cancer, more research continues to be conducted on the benefits of certain foods in reducing people's risk of contracting these ailments. Legumes in particular are often cited as being high in antioxidants, which have the property of being able to fight off free radical cells within the body, reducing the risk of cancer and other chronic diseases.
Source: www.medicalnewstoday.comBoots Centre For Innovation Brings New Permanent Hair Reduction Technology To The Home Another innovative new product from Boots Centre for Innovation will be available in Boots stores from 9 February with the launch of Boots Smooth Skin, an exclusive, first-to-market product with Intense Pulsed Light (IPL) by iPulse to reduce body hair permanently.
Source: www.medicalnewstoday.comHuge Attendance At Autism Sunday Service In London Parents, carers, children and Adults with Autism and Asperger's Syndrome joined parliamentarians and dignitaries at one of the largest churches of the east sude of London, All Saint's Church in Woodford Wells on Autism Sunday - the International Day of Prayer for Autism and Asperger's Syndrome. The reading was by the Financial Secretary Rt.Hon.Stephen Timms MP and Ellie Zavaroni.
Source: www.medicalnewstoday.comPut An End To Excessive Legal Costs, Says Medical Defence Union, UK Following today's announcement that clinical negligence contributions by NHS trusts in England are expected to rise by 80% next year, the MDU, the UK's leading medical defence organisation, said it agreed with the NHS Litigation Authority that disproportionate legal costs awarded to claimants' solici
Source: www.medicalnewstoday.comWomen Spending Five Minutes On Contraception And Worrying About Pregnancy New Fpa Research Shows According to new figures launched today by fpa (Family Planning Association) almost one in three UK women aged 18-49 typically spends up to just five minutes selecting a suitable contraceptive method to use. Yet, almost half of these women (47%) have had a pregnancy scare (thinking they were or could be pregnant when they didn't want to be).
Source: www.medicalnewstoday.comRexahn Pharmaceuticals, Inc. Initiates Clinical Trial Of Serdaxin(TM) To Treat Depression Rexahn Pharmaceuticals, Inc. (NYSE Alternext US: RNN), a leader in development of innovative therapeutics for life-threatening and life-debilitating diseases, announced today that it has initiated a Phase IIa clinical trial for Serdaxin(TM), for the treatment of major depressive disorder (MDD). The Serdaxin Phase IIa study calls for the recruitment of up to 100 patients to evaluate its preliminary efficacy in treating MDD.
Source: www.medicalnewstoday.comEditorial Suggests Black Parents Learn More About Advances In Medical Research "Black parents owe it to their children ... to become more sophisticated about how American medical policy evolved over the decades," a Pittsburgh Post-Gazette editorial states.
Source: www.medicalnewstoday.com
# posted by Network @ 9:36 PM
